Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic Dermatitis

NCT03351777 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
120
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Realm Therapeutics, Inc.